Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years

Endocrine Journal

Volumn 53, Issue 4, 2006, Pages 531-538

  Sato, Kanji ^a   Shiga, Tsuyoshi ^a   Matsuda, Naoki ^a   Onoda, Noritaka ^a   Takano, Kazue ^a   Hagiwara, Nobuhisa ^a   Kasanuki, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Amiodarone; Anti thyroid hormone antibody; Thyrotoxicosis; Type II amiodarone induced thyrotoxicosis

Indexed keywords

AMIODARONE; IODINE; PREDNISOLONE; THIAMAZOLE; THYROID HORMONE; THYROXINE;

ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DOPPLER FLOWMETRY; DOSE RESPONSE; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; LABORATORY TEST; LUNG FIBROSIS; MALE; RADIOIMMUNOASSAY; RECURRENT DISEASE; THYROTOXICOSIS;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; AUTOANTIBODIES; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; TACHYCARDIA; THYROGLOBULIN; THYROTOXICOSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33748447477     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-027     Document Type: Article

References (30)

1. Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22: 240-254.
2. Basaria S, Cooper DS (2005) Amiodarone and the thyroid. Am J Med 118: 706-714.
3. Roffi M, Cattaneo F, Brandle M (2005) Thyrotoxicosis and the cardiovascular system. Minerva Endocrinol 30: 47-58.
4. Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE, Pinchera A (1994) Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 134: 2277-2282.
5. Nakajima K, Yamazaki K, Yamada E, Kanaji Y, Kosaka S, Sato K, Takano K (2001) Amiodarone stimulates interleukin-6 production in cultured human thyrocytes, exerting cytotoxic effects on thyroid follicles in suspension culture. Thyroid 11: 101-109.
6. Sato K, Miyakawa M, Eto M, Inaba T, Matsuda N, Shiga T, Ohnishi S, Kasanuki H (1999) Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. Endocr J 46: 443-451.
7. Shiga T, Wakaumi N, Matsuda N, Shoda M, Hagiwara N, Sato K, Kasanuki H (2001) Amiodarone-induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. Jpn Circ J 65: 958-960.
8. Trip MD, Duren DR, Wiersinga WM (1994) Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. Br Heart J 72 : 266-268.
9. Dietlein M, Schicha H (2005) Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. Exp Clin Endocrinol Diabetes 113: 145-151.
10. Salamon E, Rowe RC, Faiman C (1989) Amiodarone-related cyclic thyroid dysfunction. CMAJ 141: 1247-1249.
11. Leenhardt A Jr, Milliez P, Extarmiana F, Collot M, Coumel P (2001) Amiodarone is not definitively contraindicated in patients having experienced Hyperthyroidism [abstract 3305]. Circulation (Suppl. II): II-701.
12. Osman F, Franklin JA, Sheppard MC, Gammage MD (2002) Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 105: 1275-1277.
13. Holt DW, Tucker GT, Jackson PR, Storey GCA (1983) Amiodarone pharmacokinetics. Am Heart J 106: 840-847.
14. Endoh Y, Hanai R, Uto K, Uno M, Nagashima H, Narimatsu A, Takizawa T, Onishi S, Kasanuki H (2000) KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity. Am J Cardiol 86: 229-231.
15. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E (1997) Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7 : 541-545.
16. Michotey O, Dorr R, Bourderont D, Gaya J, Rivera F, Benz R, Schmidt M (1995) Thyroid testing using the Cobas Core immunoassay system. A multicentre study. Eur J Clin Chem Clin Biochem 33: 609-622.
17. Sato K, Yamazaki K, Kanaji Y, Ohnishi S, Kasanuki H (1998) Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. Thyroid 8: 1123-1126.
18. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T (1999) Immunoglobulin G of untreated Graves' patients with or without TSH receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Thyroid 9: 979-988.
19. Sakata S, Nakamura S, Miura K (1985) Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. Ann Intern Med 103: 579-589.
20. Rotti E, Minellli R, Gardini E, Bianconi L, Braverman LE (1993) Thyrotoxicosis followed by hypothyrodism in patients treated with amiodarone: a possible consequence of a destructive process in the thyroid. Arch Intern Med 153: 886-892.
21. Yanagisawa T, Sato K, Kato Y, Shimizu S, Takano K (2005) Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. Endocr J 52: 29-36.
22. Fragu P, Schlumberger M, Davy JM, Slama M, Berdeaux A (1988) Effects of amiodarone therapy on thyroid iodine content as measured by x-ray fluorescence. J Clin Endocrinol Metab 66: 762-769.
23. Roti E, Minelli R, Gardini E, Bianconi L, Gavaruzzi G, Ugolotti G, Neri TM, Braverman LE (1992) Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 75: 1273-1277.
24. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE (1990) Iodine-induced hypothyroidism in euthyroid subjects with a previous episode of subacute thyroiditis. J Clin Endocrinol Metab 70: 1581-1585.
25. Roti E, Minelli R, Gardini E, Bianconi L, Neri T, Gavaruzzi G, Ugolotti G, Salvo D, Braverman LE (1991) Impaired intrathyroidal iodine organification and induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis. J Clin Endocrinol Metab 73: 958-963.
26. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E (2003) Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88: 1999-2002.
27. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Aldo Pinchera A, Vitti P (2000) Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 85: 2270-2274.
28. Georgopoulos NA, Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG (2003) Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149: 287-292.
29. Takeshita A, Nagayama Y, Yokoyama N, Ishikawa N, Ito K, Yamashita T, Obara T, Murakami Y, Kuma K, Takamatsu J, Ohsawa N, Nagataki S (1995) Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab 80: 2607-2611.
30. Ryan LE, Braverman LE, Cooper DS, Ladenson PW, Kloos RT (2004) Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Thyroid 14: 149-153.